Cerity Partners
AVNS

Cerity Partners’s Avanos Medical AVNS Stock Holding History

Cerity Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$341K Buy
24,305
+4,641
+24% +$62.5K ﹤0.01% 2521
2025
Q4 		$221K Sell
19,664
-20,294
-51% -$232K ﹤0.01% 2582
2025
Q3 		$462K Buy
39,958
+17,759
+80% +$208K ﹤0.01% 2025
2025
Q2 		$272K Buy
+22,199
New +$279K ﹤0.01% 2208
2024
Q4 		– Sell
-10,600
Closed -$255K – 2432
2024
Q3 		$255K Buy
+10,600
New +$242K ﹤0.01% 2174
2023
Q2 		– Sell
-421
Closed -$607K – 1661
2023
Q1 		$607K Buy
+421
New +$12.2K ﹤0.01% 1200

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Cerity Partners's AVNS Position: Q1 2026 in Review

Cerity Partners increased its Avanos Medical (AVNS) stake by 24% in Q1 2026, buying an estimated $62.5K and bringing the position to 24,305 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #2521.

Cerity Partners first reported a position in AVNS in Q1 2023 and has held it in 6 quarters since. The position peaked at $607K in Q1 2023. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Cerity Partners held 24,305 shares of Avanos Medical worth $341K as of Q1 2026.
  • Cerity Partners bought 4,641 Avanos Medical shares in Q1 2026, an estimated $62.5K.
  • Avanos Medical made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2521 holding.
  • Cerity Partners first reported a position in Avanos Medical in Q1 2023 and has held it in 6 quarters since.
  • Cerity Partners's Avanos Medical position peaked at $607K in Q1 2023.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.